Delivery Order SPE2DB20D3103-SPE2DB23FN3V0
Award Date 5/12/23
Potential Completion Date 5/15/23
Potential Value $2.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,306.92 firm fixed-price delivery order is for the supply of 4560488341 - Cevimeline HCL 30 mg capsules, a prescription medication. The contract has an ultimate completion date of April 5, 2023 and was awarded on April 4, 2023. AmerisourceBergen, a for-profit organization, is the prime contractor and does not have any set-aside designation. This...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,716.00 firm fixed-price delivery order is for the supply of 4557860723 - Cevimeline HCL 30 mg Capsule 100s. The award has an ultimate completion date of July 22, 2022 and was made on July 21, 2022. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,169.55 firm fixed-price delivery order is for the supply of 4,566,340 units of the prescription medication Cevimeline HCl 30 mg capsules. The contract has an ultimate completion date of November 6, 2024 and was awarded on November 5, 2024. There was no set-aside designation for this contract. AmerisourceBergen...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4561055140 Cevimeline HCL 30 mg capsules. The $3,630.50 firm fixed-price delivery order (SPE2DB23FT69B) has a completion date of May 26, 2023. It is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Cevimeline HCL 30 mg capsules. The firm-fixed-price contract has a ceiling value of $1,505.52 and a completion date of July 7, 2022. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Cevimeline HCL 30 mg capsules. The $2,200.08 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA) and has an ultimate completion date of October 26, 2023. Amerisourcebergen Drug Corp is the prime contractor for this award, and it is not associated with any set-aside designation. The company's parent organization, Cencora, Inc., holds two significant...
- This contract award, valued at $3,254.97, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CEVIMELINE HCL 30 MG CAPSULE 100S, a prescription medication. This is a firm fixed-price delivery order contract with a completion date of December 4, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,946.39 to AmerisourceBergen Drug Corp for Cevimeline HCL 30 mg capsules (100 count) on November 6, 2025, with completion scheduled for November 7, 2025. This non-competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999, running through December 2026. The pharmaceutical...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,161.98, is for the delivery of 4560957209 - CEVIMELINE HCL 30 MG CAPSULE 100S. This is a Firm Fixed Price Delivery Order contract with a completion date of May 17, 2023. The contract is not designated as a set-aside. AmerisourceBergen maintains a significant Indefinite...
- This federal contract award, with ID SPE2DB22D1017|SPE2DB24FE7GM, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,557.03 firm fixed-price delivery order is for the provision of 4562519587 - CEVIMELINE HCL 30 MG CAPSULE 100S, a generic pharmaceutical product. The contract has an ultimate completion date of October 18, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite...